Pharmaceutical Industry in
Geneva
99 companies in Pharmaceutical Industry based in Geneva — name and year of registration from the commercial register.
50 of 99 companies
Union for International Cancer Control (UICC)
Since 2006 · 51–100 empl.4.5(6)
The company's core activity is the development, manufacture and marketing of medicines, diagnostics and health products, particularly in the areas of oncology, immunology, infectious diseases, ophthalmology and neurological disorders. The company is also a world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a pioneer in diabetes treatment.
Laboratoires Bailleul International SA
Since 2012 · 11–20 empl.3.7(6)
Laboratoires Bailleul International SA is a pharmaceutical company specializing in the development and marketing of medicines, dietary supplements and dermocosmetic products. The company focuses on dermatology and develops products intended to improve patients' quality of life.
Servier (Suisse) SA
Since 1978 · 21–50 empl.
Servier (Suisse) SA is a subsidiary of the Servier Group that promotes and distributes medicines and provides information and support to healthcare professionals. The company works across therapeutic areas including oncology, cardiometabolic diseases, depression and venous disorders, offers a range of prescription medicines and does not sell products online or operate manufacturing/laboratory sites.
Skinpulse SARL
Since 1994 · 11–20 empl.
Skinpulse SARL is a specialized dermatology centre providing medical and aesthetic dermatology services. Offerings include dermatological check-ups, phototherapy, Mohs micrographic surgery and dermatologic surgery, laser treatments, injectables (hyaluronic acid, botulinum toxin), tattoo removal, body-shaping procedures and chemical peels; the clinical team comprises FMH-certified dermatologists with various subspecialties.
Botavie SA
Since 2000 · 1–10 empl.
Botavie SA offers plant-based dietary supplements and health products formulated according to the Unani tradition and markets them online under the BOTAVIE and IRELIA brands.
SOLID Drug Development SA
Since 2010 · 1–10 empl.
The core activity of Solid Drug Development is strategic and operational consulting for the development of biotech and pharmaceutical products. Specifically, the company supports the development of medicines from the laboratory phase to clinical testing and helps reduce costs and operational problems for pharmaceutical companies.
EHC (EUROPEAN HEALTH CORPORATION) SA
Since 2010 · 1–10 empl.
EHC (EUROPEAN HEALTH CORPORATION) SA develops and commercializes consumer healthcare and self-care products, including OTC medicines, medical devices and dietary supplements. The company conducts acquisitions, in-/out-licensing, distribution and brand promotion, and partners with distributors and laboratories to bring its products to market.
VASPERIS SA
Since 2010 · 11–20 empl.
O'TENTIKA is a cosmetics company specializing in the manufacture and distribution of skin and facial care products. The company's core activity encompasses the development, production, and sale of premium skin care products, particularly in the field of skin refinement and care.
CROSS PHARM SA
Since 2013 · 1–10 empl.
The core activity of Cross Pharm S.A. is the development, manufacture and marketing of high-quality medicines, including antibiotics, antiemetics, muscle relaxants, orexigenics and vitamins as well as minerals.
ReMedys Foundation
Since 2013 · 11–20 empl.
The core activity of ReMedys is to develop and promote innovative therapeutic approaches for patients with severe diseases without effective treatment, regardless of their commercial potential. To this end, ReMedys works in partnership with academic research institutions and industry experts to translate research results into clinical trials and develops new medicines in a project-based approach.
Bailleul (Suisse) SA
Since 2014 · 11–20 empl.
Bailleul (Suisse) SA is a pharmaceutical company specializing in the development and commercialization of medicinal products, dietary supplements and dermo‑cosmetic products.
ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Since 2014 · 11–20 empl.
The core activity of Advanced Accelerator Applications (AAA) is the development and delivery of products and services in the field of nuclear medicine, particularly in the areas of radioligand therapy (RLT) and molecular imaging with positron emission tomography (PET).
Santen SA
Since 2014 · 101–500 empl.
The company's core activity is the development, manufacture and marketing of pharmaceutical products in the field of ophthalmology, with the aim of developing innovative and effective solutions for the treatment of eye diseases and providing added value to patients and society.
DermAbiotech Sàrl
Since 2014 · 1–10 empl.
DermAbiotech Sàrl develops targeted therapies for acute T cell–mediated inflammatory diseases. The company focuses on therapeutic candidates designed to modulate T‑cell driven inflammation.
CELL RECEPTOR SA
Since 2015 · 1–10 empl.
CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.
Kyowa Kirin Sàrl
Since 2016 · 21–50 empl.
The core activity of Krystal Biotech, Inc. is the development and manufacture of pharmaceuticals, particularly biopharmaceuticals. The company focuses on the research and development of new therapeutics based on genetic and biotechnological methods. The company's products aim to treat various diseases and conditions, including rare genetic disorders.
Atopia Therapeutics SA
Since 2016 · 1–10 empl.
Atopia Therapeutics SA is developing a disease‑modifying therapy for asthma and other allergic diseases. Its lead candidate, ATP‑R13, is a patented recombinant protein derived from a Helicobacter pylori molecule intended for oral administration to modulate immune tolerance and reduce inflammation; the company holds an exclusive worldwide licence from the University of Zurich and is conducting IND‑enabling activities.
STALICLA SA
Since 2017 · 11–20 empl.
STALICLA SA is a biopharmaceutical company developing precision medicines and clinical programs for neurodevelopmental and neuropsychiatric disorders. It uses the DEPI neuro-precision platform, combining multi-omics, patient data and AI to identify subgroups and match patients with drug treatments.
iOnctura SA
Since 2017 · 21–50 empl.
The core activity of iOnctura is the development of cancer drugs, particularly in oncology immunotherapy, with a focus on solid tumors, uveal melanoma and other types of cancer.
Gliapharm SA
Since 2017 · 11–20 empl.
Gliapharm SA develops medicines that target glial cells to enhance brain energy metabolism and support neuronal function. The company uses its GliaX™ discovery platform to identify molecular targets and small‑molecule candidates and advances preclinical translational models and biomarkers.
Relief Therapeutics International SA
Since 2018 · 21–50 empl.
Relief Therapeutics International SA develops therapeutic solutions in neurotherapy and digital rehabilitation. The company offers combined approaches that use software, devices, data, and behavior-based applications for therapy and monitoring.
Topotarget Switzerland SA
Since 1999 · 1–10 empl.
Release Therapeutics SA
Since 2005 · 1–10 empl.
The core activity of Relief Therapeutics is the development and marketing of new, patented therapeutics for rare and ultra-rare diseases, particularly for patients with severe illnesses for which there are currently no or only limited treatment options. The company focuses on developing medications for specific diseases such as Epidermolysis Bullosa, Phenylketonuria and other rare conditions.
Advanced Biotech Laboratories Switzerland SA
Since 2010 · 21–50 empl.
The core activity of Advanced Biotech Laboratories Switzerland SA is the selection and promotion of high-quality anti-aging products and luxury health services, particularly in the field of cell therapy and stem cell research. The company collaborates with various clinics and laboratories to offer innovative products and services in the field of health and beauty.
Geneva Biotech Center (GBC) SA
Since 2013 · 11–20 empl.
The core activity of Atopia Tx is the development of innovative therapies for asthma and allergic diseases, in particular the development of a first disease-modifying therapeutic for asthma and allergies based on a molecule from Helicobacter pylori.
Life Episteme Group Sàrl
Since 2013 · 1–10 empl.
PhytoCloud SA
Since 2017 · 1–10 empl.
PhytoCloud SA sells cannabis-derived THC and CBD products such as vape pods, e-liquids, cartridges and olfactory inhalers. The company also offers wholesale and white-label services and personal product formulation, working with Swiss laboratories.
MPC Therapeutics SA
Since 2018 · 11–20 empl.
The core activity of MPC Therapeutics SA is the development of innovative products that improve the fitness, persistence and performance of cells, particularly T cells, mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs). This is achieved through modulation of mitochondrial function, specifically by targeted influence on the mitochondrial pyruvate carrier (MPC) and other key metabolic pathways. The company develops small molecules that modulate mitochondrial function to enhance the therapeutic efficacy of cell therapies.
AMAL THERAPEUTICS SA
Since 2012 · 21–50 empl.5.0(2)
The core activity of AMAL Therapeutics is the development of therapeutic cancer vaccines, particularly using its proprietary KISIMA immunization technology, which aims to stimulate the patient's immune response against cancer cells.
Pharmacros SA
Since 2019 · 1–10 empl.
The core activity of Pharmacros is the development, production and distribution of high-quality dietary supplements and wellness products, particularly based on collagen, in compliance with ISO and GMP standards.
RegulaNova Sàrl
Since 2020 · 1–10 empl.
FRILAB SA
Since 2002 · 21–50 empl.4.0(1)
FRILAB SA is a pharmaceutical company that markets product lines for family health, gynecology, food supplements and hospital products. It develops products in-house, acquires or licenses medicines and coordinates registration, distribution and pharmacovigilance for international markets.
Synnergan Sàrl
Since 2021 · 1–10 empl.
The core activity of Synnergan is the development and manufacture of patented dietary supplements, particularly in the areas of fat loss and muscle building. These products are manufactured in Switzerland and are based on scientific findings and research results.
ARmox Pharma Sàrl
Since 2015 · 11–20 empl.5.0(1)
The core activity of Armox Swiss Pharma is the development, manufacture and marketing of pharmaceutical products, including over-the-counter (OTC) medications, cosmetic products and generic drugs (RX products).
Rebio Pharma Sàrl
Since 2025 · 1–10 empl.
Rebio Pharma Sàrl develops targeted, locally delivered therapies for ocular oncology. Its work focuses on drug candidates and a proprietary platform for precise drug exposure, with programs in indications such as uveal melanoma and retinoblastoma.
AZURECELL SA
Since 2025 · 1–10 empl.
AZURECELL SA is a biotechnology research company. The website indicates work related to restoring neural function and points to an upcoming focus in neuroscience.
Velden Botanicals S.A.
Since 2025 · 1–10 empl.
Velden Botanicals S.A. supplies botanical ingredients for beauty, flavour, and fragrance manufacturers. The company develops traceable, standardised botanical extracts and fractions and also provides samples and technical documentation for formulation work.
ApoTalic Sàrl
Since 2025 · 1–10 empl.
ApoTalic Sàrl provides temporary pharmacy cover and pharmaceutical services, including prescription review, medication dispensing and patient counselling.
Columed SA
Since 2010 · 1–10 empl.
Columed SA provides commercial and legal services in the pharmaceutical sector and is also active in pharmaceutical retail. It offers services to both manufacturers and retailers of pharmaceutical products.
Medicoop SA
Since 2019 · 11–20 empl.
Medicoop SA supplies original, CE‑marked medical devices through B2B procurement channels within the EU. It serves hospitals, clinics and healthcare procurement organizations with essential medical products in volume and does not engage with private individuals or individual practitioners.
Swiss Armonia Sàrl
Since 2025 · 1–10 empl.
Swiss Armonia Sàrl operates the SwissWay brand for dietary supplements. The company develops and quality-controls its formulas in Switzerland and offers products such as Swiss Vue, along with partner and business solutions.
Hypericum Suisse Sàrl
Since 2025 · 1–10 empl.
Hypericum Suisse Sàrl offers liposomal dietary supplements and provides information on its products, ordering options, and product details. The company presents supplement products with a focus on simple use and daily balance.
Nirkana Sàrl
Since 2025 · 1–10 empl.
Nirkana Sàrl sells legal CBD hemp products in Switzerland, including indoor-grown flowers and other garden items. The company offers selected cannabis strains with THC below 1% and provides information on cultivation, assortment, and ordering.
Xelios Pharmaresearch, A. Hügin
Since 2003 · 1–10 empl.
The core activity of Xelios PharmaResearch is the development of new drugs for the treatment of specific skin diseases, in particular the discovery and development of treatments for Molluscum contagiosum, a viral skin infection. The activities include the identification of active ingredients, the acquisition of intellectual property rights and the conduct of clinical trials up to Phase II.
Beijing Tong Ren Tang Swiss SA
Since 2017 · 1–10 empl.
Aleos Bio SA
Since 2025 · 1–10 empl.
Inter Promotion et Publicité SA
Since 1948 · 1–10 empl.
Laboratoire Acbel SA
Since 1958 · 1–10 empl.
Labiol SA
Since 1962 · 1–10 empl.
PROPHARMED INTERNATIONAL SA
Since 1983 · 1–10 empl.
Pharmaceutical Industry in Geneva
Pharmaceutical Industry in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 10, 2026
Pharmaceutical Industry in other places
By canton